U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C58H73N7O17
Molecular Weight 1140.2369
Optical Activity UNSPECIFIED
Defined Stereocenters 15 / 15
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ANIDULAFUNGIN

SMILES

[H][C@@]12C[C@@H](O)CN1C(=O)[C@@]([H])(NC(=O)[C@H](C[C@@H](O)[C@@H](O)NC(=O)[C@]3([H])[C@@H](O)[C@@H](C)CN3C(=O)[C@@]([H])(NC(=O)[C@@]([H])(NC2=O)[C@H](O)[C@@H](O)C4=CC=C(O)C=C4)[C@@H](C)O)NC(=O)C5=CC=C(C=C5)C6=CC=C(C=C6)C7=CC=C(OCCCCC)C=C7)[C@@H](C)O

InChI

InChIKey=JHVAMHSQVVQIOT-MFAJLEFUSA-N
InChI=1S/C58H73N7O17/c1-5-6-7-24-82-40-22-18-35(19-23-40)33-10-8-32(9-11-33)34-12-14-37(15-13-34)51(74)59-41-26-43(70)54(77)63-56(79)47-48(71)29(2)27-65(47)58(81)45(31(4)67)61-55(78)46(50(73)49(72)36-16-20-38(68)21-17-36)62-53(76)42-25-39(69)28-64(42)57(80)44(30(3)66)60-52(41)75/h8-23,29-31,39,41-50,54,66-73,77H,5-7,24-28H2,1-4H3,(H,59,74)(H,60,75)(H,61,78)(H,62,76)(H,63,79)/t29-,30+,31+,39+,41-,42-,43+,44-,45-,46-,47-,48-,49-,50-,54+/m0/s1

HIDE SMILES / InChI

Molecular Formula C58H73N7O17
Molecular Weight 1140.2369
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 15 / 15
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 16:17:29 UTC 2023
Edited
by admin
on Fri Dec 15 16:17:29 UTC 2023
Record UNII
9HLM53094I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ANIDULAFUNGIN
EMA EPAR   INN   MART.   MI   ORANGE BOOK   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
VER002
Code English
LY-303366
Code English
ANIDULAFUNGIN [ORANGE BOOK]
Common Name English
Anidulafungin [WHO-DD]
Common Name English
D70013
Code English
ANIDULAFUNGIN [VANDF]
Common Name English
LY303366
Code English
ERAXIS
Brand Name English
ANIDULAFUNGIN [USAN]
Common Name English
ECHINOCANDIN B, 1-((4R,5R)-4,5-DIHYDROXY-N(SUP 2)-((4''-(PENTYLOXY)(1,1':4',1''-TERPHENYL)-4-YL)CARBONYL)-L-ORNITHINE)-
Common Name English
V-ECHINOCANDIN
Common Name English
(4R,5R)-4,5-DIHYDROXY-N(SUP 2)-((4''-(PENTYLOXY)-P-TERPHENYL-4-YL)CARBONYL)-L-ORNITHYL-L-THREONYL-TRANS-4-HYDROXY-L-PROLYL-(S)-4-HYDROXY-4-(P-HYDROXYPHENYL)-L-THREONYL-L-THREONYL-(3S,4S)-3-HYDROXY-4-METHYL-L-PROLINE CYCLIC (6->1)-PEPTIDE
Common Name English
VER-002
Code English
ANIDULAFUNGIN [MART.]
Common Name English
ANIDULAFUNGIN [EMA EPAR]
Common Name English
D-70013
Code English
anidulafungin [INN]
Common Name English
ANIDULAFUNGIN [MI]
Common Name English
Classification Tree Code System Code
LIVERTOX 58
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
NDF-RT N0000175508
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
NDF-RT N0000175507
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
NCI_THESAURUS C514
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
WHO-ATC J02AX06
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
NDF-RT N0000175508
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
WHO-VATC QJ02AX06
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
Code System Code Type Description
MERCK INDEX
m1919
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY Merck Index
NCI_THESAURUS
C38716
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
DRUG BANK
DB00362
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
FDA UNII
9HLM53094I
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
DRUG CENTRAL
4357
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
WIKIPEDIA
ANIDULAFUNGIN
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
EVMPD
SUB22240
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
CAS
166663-25-8
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
SMS_ID
100000089572
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
RXCUI
341018
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY RxNorm
USAN
KK-25
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
CHEBI
55346
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
ChEMBL
CHEMBL264241
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
INN
7795
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
MESH
C102786
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
EPA CompTox
DTXSID50873201
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
PUBCHEM
166548
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
DAILYMED
9HLM53094I
Created by admin on Fri Dec 15 16:17:29 UTC 2023 , Edited by admin on Fri Dec 15 16:17:29 UTC 2023
PRIMARY
Related Record Type Details
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
METABOLIC ENZYME -> NON-SUBSTRATE
WAS NOT A SUBSTRATE FOR ANY OTHER CYP ENZYME
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
METABOLIC ENZYME -> NON-INHIBITOR
DID NOT INHIBIT ANY OTHER CYP ENZYMES
METABOLIC ENZYME -> NON-INDUCER
DID NOT INDUCE ANY OTHER CYP ENZYMES
EXCRETED UNCHANGED
Based on the results of the mass balance study, approximately 10% of the administered dose were excreted in feces and none of the administered dose was excreted in urine.
BINDER->LIGAND
BINDING
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC